Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia (Schleicher O et al. Front Oncol, September 2022)

Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia
Schleicher O et al. Front Oncol. September 2022 – open access publication

 

 

 

Recent progress in the management of pediatric chronic myeloid leukemia - Review (Shima H. and Shimada H. Int J Hematol, December 2022)

Recent progress in the management of pediatric chronic myeloid leukemia – Review
Shima H and Shimada H. Int J Hematol, December 2022 (epub ahead of print)

 

 

 

Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors (Nishiyam-Fujita Y et al. Ann Med, December 2022)

Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors
Nishiyama-Fujita Y et al. Ann Med, December 2022 – open access publication

 

 

 

Alterations in cellular metabolism after TKI therapy for Philadelphia chromosome-positive leukemia in children: A review (Li C et al. Front Oncol, December 2022)

Alterations in cellular metabolism after TKI therapy for Philadelphia chromosome-positive leukemia in children: A review
Li C et al. Front Oncol, December 2022 – open access publication

 

 

 

Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course (Delehaye F et al. Ann Hematol, Nov 2022)

Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course
Delehaye F et al. Ann Hematol, November 2022 (epub ahead of print)

 

 

 

  1. Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment (Karadas N et al. Int J Hematol, Nov 2022)
  2. Outcome of pediatric chronic myeloid leukemia with management focusing on gene transcript levels (Al-Ghamblas I et al. Int J Pediatr Adolesc Med, September 2022)
  3. Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatrc pts with Philadelphia chromosome-positive leukemias: are age and comorbidities only to blame? (Kiliçasian NA et al. Expert Rev Respir Med, September 2022)
  4. Secondary pseudotumor cerebri syndrome in a child with chronic myeloid leukemia: Report of a case and review of previous cases (Rasmussen AH et al. Pediatr Blood Cancer, September 2022)